New to Meducation?
Sign up
Already signed up?
Log In
Add To Boards
Add
Upvote
1
CPD Tracker
00:00
Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (audio)
Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.
#Oncology
x
#Respiratory
x
#InternalMedicine
x
#MedicalOncology
x
#PulmonaryMedicine
x
#LungNeoplasms
x
#Mutation
x
Help by adding tags...
Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (audio)
- Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.
1
29
Trending
Cranial Nerves - Anatomy, Clinical Signs and Study Tips
- This is a teaching resource that aids the student in memorisation of the Cranial Nerves, their anatomical path and function. Additionally, it stimulates a clinical approach to the functions of t...
1186
40270
Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (video)
- Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.
1
24
Antiangiogenesis in First Line NSCLC (Audio)
- This presentation by medical oncologist and lung cancer expert Dr. Jack West introduces the concept of angiogenesis, with a focus on the combination of Avastin (bevacizumab) with chemotherapy for ...
1
20
EGFR Testing Not Done in 25% of Lung Cancer Patients
- Not all patients with advanced NSCLC undergo testing for the EGFR mutation, and for some patients who do undergo testing, therapy is initiated before the results are received.
0
14
First-Line Nivolumab Monotherapy in Advanced NSCLC
- Recent studies indicate that immune mechanisms play a vital role in the origin of lung cancer. Is distortion of immune checkpoints the chief culprit?
0
12
Primary Immunodeficiency Diseases
- A clear illustration of immunodeficiency disorders.
58
7173